SynapCell

SynapCell

Pharmaceutical Manufacturing Saint-ismier, Isère, Fr 42 employees
Employees
42
Contacts
2
Emails
2

SynapCell Overview

Headquarters
Saint-ismier, Isère, Fr
Phone Number
Available in AeroLeads
Website
synapcell.com
Industry
Pharmaceutical Manufacturing
Employees
42
Founded
2005
Funding
4.4M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About SynapCell

SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such as schizophrenia. Since 2005, our returning customers in USA, Japan, Korea or Europe helped the company establish a unique reputation on the market and is the basis for long-lasting successful business partnerships.

SynapCell Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

SynapCell Org Chart

Sample employees and titles
Name Title Contact
Yann Roche CEO & Founder, Synapcell - Innovations
View
Venceslas Duveau Head of Sales and Product Development
View
Antoine Depaulis Neuroscientist in Epileptology
Email
Laetitia Roche
Email

Employees by Management Level

Individual contributor 6 profiles
VP / Head 3 profiles
Manager 2 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 0
Operations 2 2 0
Marketing 1 1 0

SynapCell Tech Stack

Engineering 1 profile

Compare Similar Companies to SynapCell